nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—HTR1A—Penbutolol—coronary artery disease	0.133	0.216	CbGbCtD
Vilazodone—CYP3A4—Ticagrelor—coronary artery disease	0.0435	0.0707	CbGbCtD
Vilazodone—CYP3A4—Fenofibrate—coronary artery disease	0.0387	0.063	CbGbCtD
Vilazodone—CYP2D6—Niacin—coronary artery disease	0.032	0.052	CbGbCtD
Vilazodone—CYP3A4—Gemfibrozil—coronary artery disease	0.031	0.0504	CbGbCtD
Vilazodone—CYP2D6—Timolol—coronary artery disease	0.0298	0.0484	CbGbCtD
Vilazodone—CYP3A4—Clopidogrel—coronary artery disease	0.0269	0.0437	CbGbCtD
Vilazodone—CYP2D6—Captopril—coronary artery disease	0.0262	0.0426	CbGbCtD
Vilazodone—CYP2D6—Simvastatin—coronary artery disease	0.0253	0.0411	CbGbCtD
Vilazodone—CYP3A4—Eplerenone—coronary artery disease	0.025	0.0406	CbGbCtD
Vilazodone—CYP2D6—Lovastatin—coronary artery disease	0.0248	0.0403	CbGbCtD
Vilazodone—CYP2D6—Pravastatin—coronary artery disease	0.0248	0.0403	CbGbCtD
Vilazodone—CYP2D6—Atorvastatin—coronary artery disease	0.0226	0.0367	CbGbCtD
Vilazodone—CYP3A4—Enalapril—coronary artery disease	0.0223	0.0362	CbGbCtD
Vilazodone—CYP3A4—Ezetimibe—coronary artery disease	0.0173	0.0281	CbGbCtD
Vilazodone—CYP3A4—Rosuvastatin—coronary artery disease	0.0173	0.0281	CbGbCtD
Vilazodone—CYP3A4—Simvastatin—coronary artery disease	0.0161	0.0262	CbGbCtD
Vilazodone—CYP3A4—Lovastatin—coronary artery disease	0.0157	0.0256	CbGbCtD
Vilazodone—CYP3A4—Pravastatin—coronary artery disease	0.0157	0.0256	CbGbCtD
Vilazodone—CYP3A4—Atorvastatin—coronary artery disease	0.0143	0.0233	CbGbCtD
Vilazodone—CYP3A4—Losartan—coronary artery disease	0.0131	0.0213	CbGbCtD
Vilazodone—Aripiprazole—HTR7—coronary artery disease	0.000847	0.35	CrCbGaD
Vilazodone—Aripiprazole—ADRB1—coronary artery disease	0.000725	0.3	CrCbGaD
Vilazodone—Aripiprazole—HTR2A—coronary artery disease	0.000426	0.176	CrCbGaD
Vilazodone—Trazodone—HTR2A—coronary artery disease	0.000424	0.175	CrCbGaD
Vilazodone—Fatigue—Valsartan—coronary artery disease	0.000291	0.00109	CcSEcCtD
Vilazodone—Paraesthesia—Pravastatin—coronary artery disease	0.000291	0.00109	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.00029	0.00109	CcSEcCtD
Vilazodone—Dizziness—Acetylsalicylic acid—coronary artery disease	0.00029	0.00109	CcSEcCtD
Vilazodone—Fatigue—Olmesartan—coronary artery disease	0.00029	0.00109	CcSEcCtD
Vilazodone—Dyspepsia—Niacin—coronary artery disease	0.000289	0.00108	CcSEcCtD
Vilazodone—Mental disorder—Ramipril—coronary artery disease	0.000289	0.00108	CcSEcCtD
Vilazodone—Dry mouth—Furosemide—coronary artery disease	0.000289	0.00108	CcSEcCtD
Vilazodone—Malnutrition—Ramipril—coronary artery disease	0.000287	0.00108	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000286	0.00107	CcSEcCtD
Vilazodone—Nervous system disorder—Perindopril—coronary artery disease	0.000286	0.00107	CcSEcCtD
Vilazodone—Decreased appetite—Niacin—coronary artery disease	0.000286	0.00107	CcSEcCtD
Vilazodone—Arthralgia—Losartan—coronary artery disease	0.000285	0.00107	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.000285	0.00107	CcSEcCtD
Vilazodone—Dyspepsia—Pravastatin—coronary artery disease	0.000285	0.00107	CcSEcCtD
Vilazodone—Insomnia—Trandolapril—coronary artery disease	0.000284	0.00107	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Niacin—coronary artery disease	0.000284	0.00106	CcSEcCtD
Vilazodone—Skin disorder—Perindopril—coronary artery disease	0.000283	0.00106	CcSEcCtD
Vilazodone—Insomnia—Enalapril—coronary artery disease	0.000283	0.00106	CcSEcCtD
Vilazodone—Mental disorder—Timolol—coronary artery disease	0.000283	0.00106	CcSEcCtD
Vilazodone—Paraesthesia—Trandolapril—coronary artery disease	0.000282	0.00106	CcSEcCtD
Vilazodone—Hyperhidrosis—Perindopril—coronary artery disease	0.000282	0.00106	CcSEcCtD
Vilazodone—Decreased appetite—Pravastatin—coronary artery disease	0.000281	0.00105	CcSEcCtD
Vilazodone—Dysgeusia—Ramipril—coronary artery disease	0.000281	0.00105	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000281	0.00105	CcSEcCtD
Vilazodone—Asthenia—Fenofibrate—coronary artery disease	0.000281	0.00105	CcSEcCtD
Vilazodone—Paraesthesia—Enalapril—coronary artery disease	0.000281	0.00105	CcSEcCtD
Vilazodone—Malnutrition—Timolol—coronary artery disease	0.000281	0.00105	CcSEcCtD
Vilazodone—Somnolence—Trandolapril—coronary artery disease	0.000279	0.00105	CcSEcCtD
Vilazodone—Insomnia—Telmisartan—coronary artery disease	0.000279	0.00105	CcSEcCtD
Vilazodone—Fatigue—Pravastatin—coronary artery disease	0.000279	0.00105	CcSEcCtD
Vilazodone—Nervousness—Ramipril—coronary artery disease	0.000279	0.00105	CcSEcCtD
Vilazodone—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000279	0.00105	CcSEcCtD
Vilazodone—Dry mouth—Losartan—coronary artery disease	0.000279	0.00105	CcSEcCtD
Vilazodone—Somnolence—Enalapril—coronary artery disease	0.000278	0.00104	CcSEcCtD
Vilazodone—Nervous system disorder—Furosemide—coronary artery disease	0.000278	0.00104	CcSEcCtD
Vilazodone—Feeling abnormal—Olmesartan—coronary artery disease	0.000277	0.00104	CcSEcCtD
Vilazodone—Paraesthesia—Telmisartan—coronary artery disease	0.000277	0.00104	CcSEcCtD
Vilazodone—Dyspepsia—Trandolapril—coronary artery disease	0.000277	0.00104	CcSEcCtD
Vilazodone—Asthenia—Clopidogrel—coronary artery disease	0.000276	0.00104	CcSEcCtD
Vilazodone—Dyspepsia—Enalapril—coronary artery disease	0.000276	0.00103	CcSEcCtD
Vilazodone—Skin disorder—Furosemide—coronary artery disease	0.000275	0.00103	CcSEcCtD
Vilazodone—Dysgeusia—Timolol—coronary artery disease	0.000275	0.00103	CcSEcCtD
Vilazodone—Asthenia—Lovastatin—coronary artery disease	0.000275	0.00103	CcSEcCtD
Vilazodone—Somnolence—Telmisartan—coronary artery disease	0.000274	0.00103	CcSEcCtD
Vilazodone—Hyperhidrosis—Furosemide—coronary artery disease	0.000274	0.00103	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000273	0.00103	CcSEcCtD
Vilazodone—Decreased appetite—Trandolapril—coronary artery disease	0.000273	0.00102	CcSEcCtD
Vilazodone—Nervousness—Timolol—coronary artery disease	0.000273	0.00102	CcSEcCtD
Vilazodone—Decreased appetite—Enalapril—coronary artery disease	0.000272	0.00102	CcSEcCtD
Vilazodone—Dyspepsia—Telmisartan—coronary artery disease	0.000272	0.00102	CcSEcCtD
Vilazodone—Insomnia—Captopril—coronary artery disease	0.000272	0.00102	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000271	0.00102	CcSEcCtD
Vilazodone—Fatigue—Trandolapril—coronary artery disease	0.000271	0.00102	CcSEcCtD
Vilazodone—Fatigue—Enalapril—coronary artery disease	0.00027	0.00101	CcSEcCtD
Vilazodone—Paraesthesia—Captopril—coronary artery disease	0.00027	0.00101	CcSEcCtD
Vilazodone—Asthenia—Ezetimibe—coronary artery disease	0.000269	0.00101	CcSEcCtD
Vilazodone—Tremor—Ramipril—coronary artery disease	0.000269	0.00101	CcSEcCtD
Vilazodone—Decreased appetite—Telmisartan—coronary artery disease	0.000268	0.00101	CcSEcCtD
Vilazodone—Nausea—Rosuvastatin—coronary artery disease	0.000268	0.00101	CcSEcCtD
Vilazodone—Diarrhoea—Fenofibrate—coronary artery disease	0.000268	0.00101	CcSEcCtD
Vilazodone—Nervous system disorder—Losartan—coronary artery disease	0.000268	0.00101	CcSEcCtD
Vilazodone—Somnolence—Captopril—coronary artery disease	0.000267	0.001	CcSEcCtD
Vilazodone—Feeling abnormal—Pravastatin—coronary artery disease	0.000267	0.001	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000267	0.000999	CcSEcCtD
Vilazodone—Fatigue—Telmisartan—coronary artery disease	0.000266	0.000998	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000266	0.000996	CcSEcCtD
Vilazodone—Vision blurred—Timolol—coronary artery disease	0.000265	0.000992	CcSEcCtD
Vilazodone—Hyperhidrosis—Losartan—coronary artery disease	0.000264	0.000991	CcSEcCtD
Vilazodone—Dyspepsia—Captopril—coronary artery disease	0.000264	0.000991	CcSEcCtD
Vilazodone—Agitation—Ramipril—coronary artery disease	0.000264	0.00099	CcSEcCtD
Vilazodone—Insomnia—Perindopril—coronary artery disease	0.000264	0.000988	CcSEcCtD
Vilazodone—Diarrhoea—Clopidogrel—coronary artery disease	0.000264	0.000988	CcSEcCtD
Vilazodone—Asthenia—Eplerenone—coronary artery disease	0.000264	0.000988	CcSEcCtD
Vilazodone—Mental disorder—Lisinopril—coronary artery disease	0.000262	0.000983	CcSEcCtD
Vilazodone—Diarrhoea—Lovastatin—coronary artery disease	0.000262	0.000982	CcSEcCtD
Vilazodone—Paraesthesia—Perindopril—coronary artery disease	0.000262	0.000981	CcSEcCtD
Vilazodone—Decreased appetite—Captopril—coronary artery disease	0.000261	0.000978	CcSEcCtD
Vilazodone—Nausea—Acetylsalicylic acid—coronary artery disease	0.000261	0.000977	CcSEcCtD
Vilazodone—Malnutrition—Lisinopril—coronary artery disease	0.00026	0.000977	CcSEcCtD
Vilazodone—Dizziness—Fenofibrate—coronary artery disease	0.000259	0.000972	CcSEcCtD
Vilazodone—Somnolence—Perindopril—coronary artery disease	0.000259	0.000972	CcSEcCtD
Vilazodone—Feeling abnormal—Trandolapril—coronary artery disease	0.000259	0.000971	CcSEcCtD
Vilazodone—Fatigue—Captopril—coronary artery disease	0.000259	0.00097	CcSEcCtD
Vilazodone—Feeling abnormal—Enalapril—coronary artery disease	0.000258	0.000967	CcSEcCtD
Vilazodone—Asthenia—Simvastatin—coronary artery disease	0.000257	0.000963	CcSEcCtD
Vilazodone—Diarrhoea—Ezetimibe—coronary artery disease	0.000257	0.000963	CcSEcCtD
Vilazodone—Flatulence—Lisinopril—coronary artery disease	0.000257	0.000962	CcSEcCtD
Vilazodone—Dyspepsia—Perindopril—coronary artery disease	0.000257	0.000962	CcSEcCtD
Vilazodone—Dysgeusia—Lisinopril—coronary artery disease	0.000255	0.000956	CcSEcCtD
Vilazodone—Dizziness—Clopidogrel—coronary artery disease	0.000255	0.000955	CcSEcCtD
Vilazodone—Paraesthesia—Furosemide—coronary artery disease	0.000254	0.000954	CcSEcCtD
Vilazodone—Feeling abnormal—Telmisartan—coronary artery disease	0.000254	0.000954	CcSEcCtD
Vilazodone—Palpitations—Ramipril—coronary artery disease	0.000254	0.000952	CcSEcCtD
Vilazodone—Decreased appetite—Perindopril—coronary artery disease	0.000253	0.00095	CcSEcCtD
Vilazodone—Dizziness—Lovastatin—coronary artery disease	0.000253	0.000949	CcSEcCtD
Vilazodone—Nervousness—Lisinopril—coronary artery disease	0.000253	0.000949	CcSEcCtD
Vilazodone—Somnolence—Furosemide—coronary artery disease	0.000252	0.000944	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000252	0.000944	CcSEcCtD
Vilazodone—Diarrhoea—Eplerenone—coronary artery disease	0.000251	0.000942	CcSEcCtD
Vilazodone—Fatigue—Perindopril—coronary artery disease	0.000251	0.000942	CcSEcCtD
Vilazodone—Vomiting—Fenofibrate—coronary artery disease	0.000249	0.000934	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000249	0.000934	CcSEcCtD
Vilazodone—Convulsion—Ramipril—coronary artery disease	0.000249	0.000933	CcSEcCtD
Vilazodone—Dizziness—Ezetimibe—coronary artery disease	0.000248	0.000931	CcSEcCtD
Vilazodone—Palpitations—Timolol—coronary artery disease	0.000248	0.00093	CcSEcCtD
Vilazodone—Feeling abnormal—Captopril—coronary artery disease	0.000247	0.000928	CcSEcCtD
Vilazodone—Insomnia—Losartan—coronary artery disease	0.000247	0.000927	CcSEcCtD
Vilazodone—Decreased appetite—Furosemide—coronary artery disease	0.000246	0.000924	CcSEcCtD
Vilazodone—Vision blurred—Lisinopril—coronary artery disease	0.000245	0.00092	CcSEcCtD
Vilazodone—Paraesthesia—Losartan—coronary artery disease	0.000245	0.00092	CcSEcCtD
Vilazodone—Vomiting—Clopidogrel—coronary artery disease	0.000245	0.000918	CcSEcCtD
Vilazodone—Diarrhoea—Simvastatin—coronary artery disease	0.000245	0.000918	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000245	0.000917	CcSEcCtD
Vilazodone—Arthralgia—Ramipril—coronary artery disease	0.000245	0.000917	CcSEcCtD
Vilazodone—Fatigue—Furosemide—coronary artery disease	0.000244	0.000916	CcSEcCtD
Vilazodone—Tremor—Lisinopril—coronary artery disease	0.000244	0.000915	CcSEcCtD
Vilazodone—Vomiting—Lovastatin—coronary artery disease	0.000243	0.000912	CcSEcCtD
Vilazodone—Somnolence—Losartan—coronary artery disease	0.000243	0.000911	CcSEcCtD
Vilazodone—Dizziness—Eplerenone—coronary artery disease	0.000243	0.000911	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000243	0.000911	CcSEcCtD
Vilazodone—Asthenia—Valsartan—coronary artery disease	0.000243	0.000909	CcSEcCtD
Vilazodone—Asthenia—Olmesartan—coronary artery disease	0.000241	0.000905	CcSEcCtD
Vilazodone—Dyspepsia—Losartan—coronary artery disease	0.000241	0.000902	CcSEcCtD
Vilazodone—Feeling abnormal—Perindopril—coronary artery disease	0.00024	0.000901	CcSEcCtD
Vilazodone—Dry mouth—Ramipril—coronary artery disease	0.000239	0.000897	CcSEcCtD
Vilazodone—Arthralgia—Timolol—coronary artery disease	0.000239	0.000896	CcSEcCtD
Vilazodone—Vomiting—Ezetimibe—coronary artery disease	0.000239	0.000895	CcSEcCtD
Vilazodone—Decreased appetite—Losartan—coronary artery disease	0.000238	0.000891	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000237	0.00089	CcSEcCtD
Vilazodone—Dizziness—Simvastatin—coronary artery disease	0.000237	0.000888	CcSEcCtD
Vilazodone—Asthenia—Niacin—coronary artery disease	0.000236	0.000884	CcSEcCtD
Vilazodone—Fatigue—Losartan—coronary artery disease	0.000236	0.000884	CcSEcCtD
Vilazodone—Dry mouth—Timolol—coronary artery disease	0.000234	0.000877	CcSEcCtD
Vilazodone—Vomiting—Eplerenone—coronary artery disease	0.000234	0.000876	CcSEcCtD
Vilazodone—Feeling abnormal—Furosemide—coronary artery disease	0.000233	0.000875	CcSEcCtD
Vilazodone—Nausea—Fenofibrate—coronary artery disease	0.000233	0.000873	CcSEcCtD
Vilazodone—Asthenia—Pravastatin—coronary artery disease	0.000232	0.000871	CcSEcCtD
Vilazodone—Diarrhoea—Valsartan—coronary artery disease	0.000231	0.000867	CcSEcCtD
Vilazodone—Palpitations—Lisinopril—coronary artery disease	0.00023	0.000863	CcSEcCtD
Vilazodone—Diarrhoea—Olmesartan—coronary artery disease	0.00023	0.000863	CcSEcCtD
Vilazodone—Nervous system disorder—Ramipril—coronary artery disease	0.00023	0.000862	CcSEcCtD
Vilazodone—Nausea—Clopidogrel—coronary artery disease	0.000229	0.000858	CcSEcCtD
Vilazodone—Skin disorder—Ramipril—coronary artery disease	0.000228	0.000854	CcSEcCtD
Vilazodone—Vomiting—Simvastatin—coronary artery disease	0.000228	0.000853	CcSEcCtD
Vilazodone—Nausea—Lovastatin—coronary artery disease	0.000227	0.000852	CcSEcCtD
Vilazodone—Hyperhidrosis—Ramipril—coronary artery disease	0.000227	0.00085	CcSEcCtD
Vilazodone—Asthenia—Trandolapril—coronary artery disease	0.000225	0.000845	CcSEcCtD
Vilazodone—Feeling abnormal—Losartan—coronary artery disease	0.000225	0.000845	CcSEcCtD
Vilazodone—Diarrhoea—Niacin—coronary artery disease	0.000225	0.000843	CcSEcCtD
Vilazodone—Nervous system disorder—Timolol—coronary artery disease	0.000225	0.000843	CcSEcCtD
Vilazodone—Asthenia—Enalapril—coronary artery disease	0.000225	0.000842	CcSEcCtD
Vilazodone—Dizziness—Valsartan—coronary artery disease	0.000224	0.000838	CcSEcCtD
Vilazodone—Nausea—Ezetimibe—coronary artery disease	0.000223	0.000836	CcSEcCtD
Vilazodone—Skin disorder—Timolol—coronary artery disease	0.000223	0.000835	CcSEcCtD
Vilazodone—Dizziness—Olmesartan—coronary artery disease	0.000222	0.000834	CcSEcCtD
Vilazodone—Arthralgia—Lisinopril—coronary artery disease	0.000222	0.000832	CcSEcCtD
Vilazodone—Hyperhidrosis—Timolol—coronary artery disease	0.000222	0.000831	CcSEcCtD
Vilazodone—Asthenia—Telmisartan—coronary artery disease	0.000221	0.000831	CcSEcCtD
Vilazodone—Diarrhoea—Pravastatin—coronary artery disease	0.000221	0.00083	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.00022	0.000826	CcSEcCtD
Vilazodone—Nausea—Eplerenone—coronary artery disease	0.000218	0.000818	CcSEcCtD
Vilazodone—Dizziness—Niacin—coronary artery disease	0.000217	0.000815	CcSEcCtD
Vilazodone—Dry mouth—Lisinopril—coronary artery disease	0.000217	0.000813	CcSEcCtD
Vilazodone—Asthenia—Captopril—coronary artery disease	0.000215	0.000808	CcSEcCtD
Vilazodone—Diarrhoea—Trandolapril—coronary artery disease	0.000215	0.000806	CcSEcCtD
Vilazodone—Vomiting—Valsartan—coronary artery disease	0.000215	0.000806	CcSEcCtD
Vilazodone—Diarrhoea—Enalapril—coronary artery disease	0.000214	0.000803	CcSEcCtD
Vilazodone—Dizziness—Pravastatin—coronary artery disease	0.000214	0.000802	CcSEcCtD
Vilazodone—Vomiting—Olmesartan—coronary artery disease	0.000214	0.000802	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000214	0.000801	CcSEcCtD
Vilazodone—Nausea—Simvastatin—coronary artery disease	0.000213	0.000797	CcSEcCtD
Vilazodone—Insomnia—Ramipril—coronary artery disease	0.000212	0.000795	CcSEcCtD
Vilazodone—Diarrhoea—Telmisartan—coronary artery disease	0.000211	0.000792	CcSEcCtD
Vilazodone—Paraesthesia—Ramipril—coronary artery disease	0.00021	0.000789	CcSEcCtD
Vilazodone—Asthenia—Perindopril—coronary artery disease	0.000209	0.000784	CcSEcCtD
Vilazodone—Vomiting—Niacin—coronary artery disease	0.000209	0.000784	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000209	0.000783	CcSEcCtD
Vilazodone—Somnolence—Ramipril—coronary artery disease	0.000208	0.000781	CcSEcCtD
Vilazodone—Dizziness—Trandolapril—coronary artery disease	0.000208	0.000779	CcSEcCtD
Vilazodone—Insomnia—Timolol—coronary artery disease	0.000207	0.000777	CcSEcCtD
Vilazodone—Dizziness—Enalapril—coronary artery disease	0.000207	0.000776	CcSEcCtD
Vilazodone—Skin disorder—Lisinopril—coronary artery disease	0.000206	0.000774	CcSEcCtD
Vilazodone—Dyspepsia—Ramipril—coronary artery disease	0.000206	0.000774	CcSEcCtD
Vilazodone—Paraesthesia—Timolol—coronary artery disease	0.000206	0.000772	CcSEcCtD
Vilazodone—Vomiting—Pravastatin—coronary artery disease	0.000206	0.000771	CcSEcCtD
Vilazodone—Hyperhidrosis—Lisinopril—coronary artery disease	0.000206	0.000771	CcSEcCtD
Vilazodone—Diarrhoea—Captopril—coronary artery disease	0.000205	0.00077	CcSEcCtD
Vilazodone—Dizziness—Telmisartan—coronary artery disease	0.000204	0.000765	CcSEcCtD
Vilazodone—Decreased appetite—Ramipril—coronary artery disease	0.000204	0.000764	CcSEcCtD
Vilazodone—Somnolence—Timolol—coronary artery disease	0.000204	0.000764	CcSEcCtD
Vilazodone—Asthenia—Furosemide—coronary artery disease	0.000203	0.000762	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000202	0.000759	CcSEcCtD
Vilazodone—Fatigue—Ramipril—coronary artery disease	0.000202	0.000758	CcSEcCtD
Vilazodone—Dyspepsia—Timolol—coronary artery disease	0.000202	0.000756	CcSEcCtD
Vilazodone—Nausea—Valsartan—coronary artery disease	0.000201	0.000753	CcSEcCtD
Vilazodone—Nausea—Olmesartan—coronary artery disease	0.0002	0.000749	CcSEcCtD
Vilazodone—Vomiting—Trandolapril—coronary artery disease	0.0002	0.000749	CcSEcCtD
Vilazodone—Diarrhoea—Perindopril—coronary artery disease	0.000199	0.000748	CcSEcCtD
Vilazodone—Decreased appetite—Timolol—coronary artery disease	0.000199	0.000747	CcSEcCtD
Vilazodone—Vomiting—Enalapril—coronary artery disease	0.000199	0.000746	CcSEcCtD
Vilazodone—Dizziness—Captopril—coronary artery disease	0.000199	0.000744	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Timolol—coronary artery disease	0.000198	0.000742	CcSEcCtD
Vilazodone—Fatigue—Timolol—coronary artery disease	0.000198	0.000741	CcSEcCtD
Vilazodone—Vomiting—Telmisartan—coronary artery disease	0.000196	0.000736	CcSEcCtD
Vilazodone—Asthenia—Losartan—coronary artery disease	0.000196	0.000735	CcSEcCtD
Vilazodone—Nausea—Niacin—coronary artery disease	0.000195	0.000732	CcSEcCtD
Vilazodone—Diarrhoea—Furosemide—coronary artery disease	0.000194	0.000727	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000194	0.000726	CcSEcCtD
Vilazodone—Feeling abnormal—Ramipril—coronary artery disease	0.000193	0.000724	CcSEcCtD
Vilazodone—Dizziness—Perindopril—coronary artery disease	0.000193	0.000723	CcSEcCtD
Vilazodone—Insomnia—Lisinopril—coronary artery disease	0.000192	0.000721	CcSEcCtD
Vilazodone—Nausea—Pravastatin—coronary artery disease	0.000192	0.000721	CcSEcCtD
Vilazodone—Paraesthesia—Lisinopril—coronary artery disease	0.000191	0.000716	CcSEcCtD
Vilazodone—Vomiting—Captopril—coronary artery disease	0.000191	0.000716	CcSEcCtD
Vilazodone—Somnolence—Lisinopril—coronary artery disease	0.000189	0.000709	CcSEcCtD
Vilazodone—Feeling abnormal—Timolol—coronary artery disease	0.000189	0.000708	CcSEcCtD
Vilazodone—Dizziness—Furosemide—coronary artery disease	0.000187	0.000703	CcSEcCtD
Vilazodone—Dyspepsia—Lisinopril—coronary artery disease	0.000187	0.000702	CcSEcCtD
Vilazodone—Diarrhoea—Losartan—coronary artery disease	0.000187	0.000701	CcSEcCtD
Vilazodone—Nausea—Trandolapril—coronary artery disease	0.000187	0.0007	CcSEcCtD
Vilazodone—Nausea—Enalapril—coronary artery disease	0.000186	0.000697	CcSEcCtD
Vilazodone—Vomiting—Perindopril—coronary artery disease	0.000185	0.000695	CcSEcCtD
Vilazodone—Decreased appetite—Lisinopril—coronary artery disease	0.000185	0.000693	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000184	0.000688	CcSEcCtD
Vilazodone—Nausea—Telmisartan—coronary artery disease	0.000183	0.000688	CcSEcCtD
Vilazodone—Fatigue—Lisinopril—coronary artery disease	0.000183	0.000687	CcSEcCtD
Vilazodone—Dizziness—Losartan—coronary artery disease	0.000181	0.000678	CcSEcCtD
Vilazodone—Vomiting—Furosemide—coronary artery disease	0.00018	0.000675	CcSEcCtD
Vilazodone—Nausea—Captopril—coronary artery disease	0.000178	0.000669	CcSEcCtD
Vilazodone—Feeling abnormal—Lisinopril—coronary artery disease	0.000175	0.000657	CcSEcCtD
Vilazodone—Vomiting—Losartan—coronary artery disease	0.000174	0.000652	CcSEcCtD
Vilazodone—Nausea—Perindopril—coronary artery disease	0.000173	0.000649	CcSEcCtD
Vilazodone—Nausea—Furosemide—coronary artery disease	0.000168	0.000631	CcSEcCtD
Vilazodone—Asthenia—Ramipril—coronary artery disease	0.000168	0.000631	CcSEcCtD
Vilazodone—Asthenia—Timolol—coronary artery disease	0.000164	0.000617	CcSEcCtD
Vilazodone—Nausea—Losartan—coronary artery disease	0.000162	0.000609	CcSEcCtD
Vilazodone—Diarrhoea—Ramipril—coronary artery disease	0.00016	0.000601	CcSEcCtD
Vilazodone—Diarrhoea—Timolol—coronary artery disease	0.000157	0.000588	CcSEcCtD
Vilazodone—Dizziness—Ramipril—coronary artery disease	0.000155	0.000581	CcSEcCtD
Vilazodone—Asthenia—Lisinopril—coronary artery disease	0.000153	0.000572	CcSEcCtD
Vilazodone—Dizziness—Timolol—coronary artery disease	0.000152	0.000568	CcSEcCtD
Vilazodone—Vomiting—Ramipril—coronary artery disease	0.000149	0.000559	CcSEcCtD
Vilazodone—Vomiting—Timolol—coronary artery disease	0.000146	0.000546	CcSEcCtD
Vilazodone—Diarrhoea—Lisinopril—coronary artery disease	0.000145	0.000545	CcSEcCtD
Vilazodone—Dizziness—Lisinopril—coronary artery disease	0.000141	0.000527	CcSEcCtD
Vilazodone—Nausea—Ramipril—coronary artery disease	0.000139	0.000522	CcSEcCtD
Vilazodone—Nausea—Timolol—coronary artery disease	0.000136	0.00051	CcSEcCtD
Vilazodone—Vomiting—Lisinopril—coronary artery disease	0.000135	0.000507	CcSEcCtD
Vilazodone—Nausea—Lisinopril—coronary artery disease	0.000126	0.000473	CcSEcCtD
Vilazodone—CYP2D6—Metabolism—ALDOA—coronary artery disease	1.25e-05	0.000107	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.24e-05	0.000107	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HK2—coronary artery disease	1.24e-05	0.000107	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP3—coronary artery disease	1.24e-05	0.000107	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT5A—coronary artery disease	1.24e-05	0.000107	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ITGAV—coronary artery disease	1.23e-05	0.000106	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KNG1—coronary artery disease	1.23e-05	0.000106	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—POMC—coronary artery disease	1.22e-05	0.000105	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CREB1—coronary artery disease	1.22e-05	0.000105	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AGTR1—coronary artery disease	1.22e-05	0.000105	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DCN—coronary artery disease	1.21e-05	0.000104	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOB—coronary artery disease	1.2e-05	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCL2—coronary artery disease	1.2e-05	0.000103	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.19e-05	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6R—coronary artery disease	1.19e-05	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCL10—coronary artery disease	1.19e-05	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PLG—coronary artery disease	1.19e-05	0.000102	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CXCL8—coronary artery disease	1.19e-05	0.000102	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—JAK2—coronary artery disease	1.18e-05	0.000102	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EDN1—coronary artery disease	1.18e-05	0.000102	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALDH2—coronary artery disease	1.18e-05	0.000101	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—coronary artery disease	1.18e-05	0.000101	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LCAT—coronary artery disease	1.17e-05	0.000101	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.17e-05	0.000101	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL5—coronary artery disease	1.17e-05	0.000101	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRB2—coronary artery disease	1.16e-05	9.98e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF1—coronary artery disease	1.15e-05	9.92e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CSF2—coronary artery disease	1.15e-05	9.92e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOA4—coronary artery disease	1.15e-05	9.91e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—LIPC—coronary artery disease	1.15e-05	9.89e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HBA1—coronary artery disease	1.15e-05	9.89e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	1.15e-05	9.89e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP2C19—coronary artery disease	1.15e-05	9.89e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LPL—coronary artery disease	1.14e-05	9.85e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCE—coronary artery disease	1.14e-05	9.85e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—JAK2—coronary artery disease	1.14e-05	9.84e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOC3—coronary artery disease	1.14e-05	9.83e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SOCS1—coronary artery disease	1.14e-05	9.83e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—S100B—coronary artery disease	1.14e-05	9.8e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—LDLR—coronary artery disease	1.13e-05	9.77e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MEF2C—coronary artery disease	1.13e-05	9.76e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RPS6KB1—coronary artery disease	1.13e-05	9.76e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SOCS3—coronary artery disease	1.12e-05	9.71e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC9A1—coronary artery disease	1.12e-05	9.65e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTT1—coronary artery disease	1.12e-05	9.65e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TGFBR2—coronary artery disease	1.11e-05	9.59e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KITLG—coronary artery disease	1.11e-05	9.59e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GCLM—coronary artery disease	1.11e-05	9.57e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.11e-05	9.57e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GCLC—coronary artery disease	1.11e-05	9.54e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CETP—coronary artery disease	1.11e-05	9.54e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ITGB3—coronary artery disease	1.1e-05	9.52e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SDC1—coronary artery disease	1.09e-05	9.43e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP3—coronary artery disease	1.09e-05	9.37e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT5A—coronary artery disease	1.09e-05	9.37e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CXCL8—coronary artery disease	1.08e-05	9.29e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.07e-05	9.27e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.07e-05	9.27e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PPP2CA—coronary artery disease	1.07e-05	9.24e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.06e-05	9.13e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCD—coronary artery disease	1.05e-05	9.08e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOB—coronary artery disease	1.05e-05	9.06e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HADH—coronary artery disease	1.04e-05	9e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.04e-05	9e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CXCL8—coronary artery disease	1.04e-05	8.98e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—JAK2—coronary artery disease	1.04e-05	8.94e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EDN1—coronary artery disease	1.03e-05	8.92e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PSMA6—coronary artery disease	1.03e-05	8.91e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PSMB5—coronary artery disease	1.03e-05	8.91e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—coronary artery disease	1.03e-05	8.88e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—C3—coronary artery disease	1.03e-05	8.87e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL5—coronary artery disease	1.03e-05	8.85e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CSF2—coronary artery disease	1.01e-05	8.71e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF1—coronary artery disease	1.01e-05	8.71e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CTGF—coronary artery disease	1.01e-05	8.71e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LPL—coronary artery disease	1e-05	8.65e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMGCR—coronary artery disease	1e-05	8.63e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GOT2—coronary artery disease	1e-05	8.63e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MEF2C—coronary artery disease	9.94e-06	8.57e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RPS6KB1—coronary artery disease	9.94e-06	8.57e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	9.89e-06	8.53e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOA2—coronary artery disease	9.89e-06	8.53e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPX2—coronary artery disease	9.89e-06	8.53e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HIF1A—coronary artery disease	9.81e-06	8.46e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AGT—coronary artery disease	9.77e-06	8.43e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	9.77e-06	8.43e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HK1—coronary artery disease	9.77e-06	8.43e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPX4—coronary artery disease	9.77e-06	8.43e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCG5—coronary artery disease	9.77e-06	8.43e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ITGB3—coronary artery disease	9.68e-06	8.35e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HADHA—coronary artery disease	9.65e-06	8.33e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LEP—coronary artery disease	9.57e-06	8.26e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOE—coronary artery disease	9.57e-06	8.26e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTA1—coronary artery disease	9.54e-06	8.23e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOA1—coronary artery disease	9.46e-06	8.16e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CXCL8—coronary artery disease	9.45e-06	8.16e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LPA—coronary artery disease	9.43e-06	8.14e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PPP2CA—coronary artery disease	9.41e-06	8.12e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KDR—coronary artery disease	9.38e-06	8.09e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	9.32e-06	8.04e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCD—coronary artery disease	9.24e-06	7.97e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLCB1—coronary artery disease	9.2e-06	7.93e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ESR1—coronary artery disease	9.14e-06	7.88e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLCB3—coronary artery disease	9.14e-06	7.88e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOA5—coronary artery disease	9.04e-06	7.8e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—coronary artery disease	9.04e-06	7.8e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—C3—coronary artery disease	9.03e-06	7.79e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FN1—coronary artery disease	9.03e-06	7.79e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—F2—coronary artery disease	9.03e-06	7.79e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	8.99e-06	7.76e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	8.92e-06	7.7e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCA1—coronary artery disease	8.91e-06	7.69e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—P4HB—coronary artery disease	8.87e-06	7.65e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	8.7e-06	7.51e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KIT—coronary artery disease	8.64e-06	7.45e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GOT1—coronary artery disease	8.63e-06	7.45e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GGT1—coronary artery disease	8.63e-06	7.45e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HIF1A—coronary artery disease	8.61e-06	7.43e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AGT—coronary artery disease	8.58e-06	7.4e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOE—coronary artery disease	8.4e-06	7.25e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LEP—coronary artery disease	8.4e-06	7.25e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOA1—coronary artery disease	8.31e-06	7.17e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	8.29e-06	7.15e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KDR—coronary artery disease	8.23e-06	7.1e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—POMC—coronary artery disease	8.22e-06	7.09e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CREB1—coronary artery disease	8.22e-06	7.09e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—VCAN—coronary artery disease	8.21e-06	7.08e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK14—coronary artery disease	8.18e-06	7.06e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALDOA—coronary artery disease	8.14e-06	7.03e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL2—coronary artery disease	8.05e-06	6.94e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ESR1—coronary artery disease	8.02e-06	6.92e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6R—coronary artery disease	8.02e-06	6.92e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FN1—coronary artery disease	7.93e-06	6.84e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—F2—coronary artery disease	7.93e-06	6.84e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1—coronary artery disease	7.91e-06	6.82e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DCN—coronary artery disease	7.9e-06	6.82e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6ST—coronary artery disease	7.89e-06	6.81e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	7.87e-06	6.79e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	7.83e-06	6.76e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTP1—coronary artery disease	7.75e-06	6.69e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALDH2—coronary artery disease	7.69e-06	6.63e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	7.68e-06	6.63e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMOX1—coronary artery disease	7.65e-06	6.6e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KIT—coronary artery disease	7.58e-06	6.54e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAT—coronary artery disease	7.55e-06	6.51e-05	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	7.52e-06	6.49e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	7.51e-06	6.48e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LIPC—coronary artery disease	7.49e-06	6.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	7.49e-06	6.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HBA1—coronary artery disease	7.49e-06	6.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	7.49e-06	6.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOC3—coronary artery disease	7.45e-06	6.43e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LDLR—coronary artery disease	7.4e-06	6.39e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOB—coronary artery disease	7.32e-06	6.32e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTT1—coronary artery disease	7.31e-06	6.31e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	7.31e-06	6.31e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GSK3B—coronary artery disease	7.28e-06	6.28e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF2—coronary artery disease	7.27e-06	6.27e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CA—coronary artery disease	7.23e-06	6.24e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GCLC—coronary artery disease	7.23e-06	6.24e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CETP—coronary artery disease	7.23e-06	6.24e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—POMC—coronary artery disease	7.22e-06	6.23e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CREB1—coronary artery disease	7.22e-06	6.23e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOS3—coronary artery disease	7.17e-06	6.19e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SDC1—coronary artery disease	7.15e-06	6.17e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTM1—coronary artery disease	7.13e-06	6.15e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL2—coronary artery disease	7.06e-06	6.09e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6R—coronary artery disease	7.04e-06	6.08e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—LPL—coronary artery disease	6.99e-06	6.03e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JAK2—coronary artery disease	6.97e-06	6.01e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1—coronary artery disease	6.94e-06	5.99e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	6.91e-06	5.96e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	6.83e-06	5.89e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GPX1—coronary artery disease	6.82e-06	5.89e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PSMA6—coronary artery disease	6.75e-06	5.83e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PSMB5—coronary artery disease	6.75e-06	5.83e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CD36—coronary artery disease	6.65e-06	5.73e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	6.6e-06	5.7e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CTGF—coronary artery disease	6.6e-06	5.69e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	6.59e-06	5.69e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	6.56e-06	5.66e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMGCR—coronary artery disease	6.54e-06	5.64e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GOT2—coronary artery disease	6.54e-06	5.64e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF2—coronary artery disease	6.38e-06	5.51e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	6.36e-06	5.49e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—coronary artery disease	6.3e-06	5.43e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOS3—coronary artery disease	6.3e-06	5.43e-05	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	6.14e-06	5.3e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JAK2—coronary artery disease	6.12e-06	5.28e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—coronary artery disease	6.09e-06	5.25e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—coronary artery disease	6.05e-06	5.22e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLCB1—coronary artery disease	6.01e-06	5.19e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	6e-06	5.17e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AGT—coronary artery disease	5.98e-06	5.16e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCND1—coronary artery disease	5.93e-06	5.11e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKT1—coronary artery disease	5.91e-06	5.1e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOE—coronary artery disease	5.86e-06	5.06e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.83e-06	5.03e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOA1—coronary artery disease	5.8e-06	5e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP9—coronary artery disease	5.75e-06	4.96e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GGT1—coronary artery disease	5.64e-06	4.87e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GOT1—coronary artery disease	5.64e-06	4.87e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCL8—coronary artery disease	5.58e-06	4.82e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	5.58e-06	4.81e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	5.39e-06	4.65e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—coronary artery disease	5.35e-06	4.61e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—coronary artery disease	5.31e-06	4.58e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCND1—coronary artery disease	5.2e-06	4.49e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	5.17e-06	4.46e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARG—coronary artery disease	5.11e-06	4.41e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.07e-06	4.37e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP9—coronary artery disease	5.05e-06	4.36e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—POMC—coronary artery disease	5.04e-06	4.35e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.02e-06	4.33e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMOX1—coronary artery disease	5e-06	4.31e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAT—coronary artery disease	4.93e-06	4.26e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT1—coronary artery disease	4.9e-06	4.23e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOB—coronary artery disease	4.79e-06	4.13e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	4.74e-06	4.09e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.66e-06	4.02e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	4.65e-06	4.01e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALB—coronary artery disease	4.59e-06	3.96e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LPL—coronary artery disease	4.57e-06	3.95e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—coronary artery disease	4.54e-06	3.91e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPX1—coronary artery disease	4.46e-06	3.85e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NOS3—coronary artery disease	4.39e-06	3.79e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CD36—coronary artery disease	4.34e-06	3.75e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.29e-06	3.7e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TGFB1—coronary artery disease	4.16e-06	3.59e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.12e-06	3.55e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK1—coronary artery disease	4.08e-06	3.52e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	4.04e-06	3.48e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—coronary artery disease	4.02e-06	3.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AGT—coronary artery disease	3.91e-06	3.38e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOE—coronary artery disease	3.83e-06	3.31e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOA1—coronary artery disease	3.79e-06	3.27e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—coronary artery disease	3.57e-06	3.08e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	3.54e-06	3.06e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARG—coronary artery disease	3.34e-06	2.88e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT1—coronary artery disease	3.3e-06	2.84e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—POMC—coronary artery disease	3.29e-06	2.84e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—coronary artery disease	3.14e-06	2.71e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALB—coronary artery disease	3e-06	2.59e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT1—coronary artery disease	2.89e-06	2.5e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NOS3—coronary artery disease	2.87e-06	2.48e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.63e-06	2.27e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.47e-06	2.13e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKT1—coronary artery disease	2.02e-06	1.74e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.62e-06	1.39e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKT1—coronary artery disease	1.32e-06	1.14e-05	CbGpPWpGaD
